These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 29794557)

  • 1. Does the Neuroimmune Modulator Ibudilast Alter Food Craving? Results in a Sample With Alcohol Use Disorder.
    Cummings JR; Tomiyama AJ; Ray LA
    J Addict Med; 2018; 12(5):410-417. PubMed ID: 29794557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of the Neuroimmune Modulator Ibudilast for the Treatment of Alcoholism: A Randomized, Placebo-Controlled, Human Laboratory Trial.
    Ray LA; Bujarski S; Shoptaw S; Roche DJ; Heinzerling K; Miotto K
    Neuropsychopharmacology; 2017 Aug; 42(9):1776-1788. PubMed ID: 28091532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized, Placebo-Controlled Trial of Targeting Neuroinflammation with Ibudilast to Treat Methamphetamine Use Disorder.
    Heinzerling KG; Briones M; Thames AD; Hinkin CH; Zhu T; Wu YN; Shoptaw SJ
    J Neuroimmune Pharmacol; 2020 Jun; 15(2):238-248. PubMed ID: 31820289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ibudilast moderates the effect of mood on alcohol craving during stress exposure.
    Meredith LR; Green R; Grodin EN; Chorpita M; Miotto K; Ray LA
    Exp Clin Psychopharmacol; 2022 Oct; 30(5):620-631. PubMed ID: 36102596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ibudilast for alcohol use disorder: study protocol for a phase II randomized clinical trial.
    Burnette EM; Baskerville WA; Grodin EN; Ray LA
    Trials; 2020 Sep; 21(1):779. PubMed ID: 32912290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ibudilast, a neuroimmune modulator, reduces heavy drinking and alcohol cue-elicited neural activation: a randomized trial.
    Grodin EN; Bujarski S; Towns B; Burnette E; Nieto S; Lim A; Lin J; Miotto K; Gillis A; Irwin MR; Evans C; Ray LA
    Transl Psychiatry; 2021 Jun; 11(1):355. PubMed ID: 34120149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ibudilast attenuates peripheral inflammatory effects of methamphetamine in patients with methamphetamine use disorder.
    Li MJ; Briones MS; Heinzerling KG; Kalmin MM; Shoptaw SJ
    Drug Alcohol Depend; 2020 Jan; 206():107776. PubMed ID: 31812878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of neuroimmune modulation on subjective response to alcohol in the natural environment.
    Meredith LR; Grodin EN; Montoya AK; Miranda R; Squeglia LM; Towns B; Evans C; Ray LA
    Alcohol Clin Exp Res; 2022 May; 46(5):876-890. PubMed ID: 35362101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nalmefene attenuates neural alcohol cue-reactivity in the ventral striatum and subjective alcohol craving in patients with alcohol use disorder.
    Karl D; Bumb JM; Bach P; Dinter C; Koopmann A; Hermann D; Mann K; Kiefer F; Vollstädt-Klein S
    Psychopharmacology (Berl); 2021 Aug; 238(8):2179-2189. PubMed ID: 33846866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ibudilast attenuates alcohol cue-elicited frontostriatal functional connectivity in alcohol use disorder.
    Burnette EM; Ray LA; Irwin MR; Grodin EN
    Alcohol Clin Exp Res; 2021 Oct; 45(10):2017-2028. PubMed ID: 34585396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous ghrelin administration increases alcohol craving in alcohol-dependent heavy drinkers: a preliminary investigation.
    Leggio L; Zywiak WH; Fricchione SR; Edwards SM; de la Monte SM; Swift RM; Kenna GA
    Biol Psychiatry; 2014 Nov; 76(9):734-41. PubMed ID: 24775991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stress, cues, and eating behavior. Using drug addiction paradigms to understand motivation for food.
    Stojek MK; Fischer S; MacKillop J
    Appetite; 2015 Sep; 92():252-60. PubMed ID: 26022802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Randomized, Double-Blind, Placebo-Controlled Trial of Citicoline in Patients with Alcohol Use Disorder.
    Brown ES; Van Enkevort E; Kulikova A; Escalante C; Nakamura A; Ivleva EI; Holmes T
    Alcohol Clin Exp Res; 2019 Feb; 43(2):317-323. PubMed ID: 30457668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of the monoamine stabilizer (-)-OSU6162 on craving in alcohol dependent individuals: A human laboratory study.
    Khemiri L; Steensland P; Guterstam J; Beck O; Carlsson A; Franck J; Jayaram-Lindström N
    Eur Neuropsychopharmacol; 2015 Dec; 25(12):2240-51. PubMed ID: 26482910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Varenicline effects on drinking, craving and neural reward processing among non-treatment-seeking alcohol-dependent individuals.
    Schacht JP; Anton RF; Randall PK; Li X; Henderson S; Myrick H
    Psychopharmacology (Berl); 2014 Sep; 231(18):3799-807. PubMed ID: 24647921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Craving in response to stress induction in a human laboratory paradigm predicts treatment outcome in alcohol-dependent individuals.
    Higley AE; Crane NA; Spadoni AD; Quello SB; Goodell V; Mason BJ
    Psychopharmacology (Berl); 2011 Nov; 218(1):121-9. PubMed ID: 21607563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prazosin effects on stress- and cue-induced craving and stress response in alcohol-dependent individuals: preliminary findings.
    Fox HC; Anderson GM; Tuit K; Hansen J; Kimmerling A; Siedlarz KM; Morgan PT; Sinha R
    Alcohol Clin Exp Res; 2012 Feb; 36(2):351-60. PubMed ID: 21919922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baseline C-reactive protein levels are predictive of treatment response to a neuroimmune modulator in individuals with an alcohol use disorder: a preliminary study.
    Grodin EN; Meredith LR; Burnette EM; Miotto K; Irwin MR; Ray LA
    Am J Drug Alcohol Abuse; 2023 May; 49(3):333-344. PubMed ID: 36282988
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparing alcohol cue-reactivity in treatment-seekers versus non-treatment-seekers with alcohol use disorder.
    Venegas A; Ray LA
    Am J Drug Alcohol Abuse; 2020; 46(1):131-138. PubMed ID: 31295037
    [No Abstract]   [Full Text] [Related]  

  • 20. The impact of treatment condition and the lagged effects of PTSD symptom severity and alcohol use on changes in alcohol craving.
    Kaczkurkin AN; Asnaani A; Alpert E; Foa EB
    Behav Res Ther; 2016 Apr; 79():7-14. PubMed ID: 26905901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.